Norman L. Lehman
Affiliations: | Pathology | Henry Ford Hospital, Detroit, MI, United States |
Google:
"Norman Lehman"Bio:
Henry Ford Hospital
Department of Pathology, Room K630
Detroit, MI 48202
United States
Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sak M, Zumbar CT, King PD, et al. (2019) Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells. Journal of Neuro-Oncology |
| Lehman NL, Usubalieva A, Lin T, et al. (2019) Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathologica Communications. 7: 42 |
| Williams B, Zumbar C, Mifsud C, et al. (2019) EXTH-46. ALISERTIB POTENTIATES THE EFFECT OF CABOZANTINIB AND VANDETANIB AGAINST GLIOBLASTOMA CELLS Neuro-Oncology. 21: vi92-vi92 |
| Zumbar CT, Usubalieva A, King PD, et al. (2018) The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells. Journal of Neuro-Oncology |
| Kondo N, Barth RF, Miyatake SI, et al. (2017) Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1 mutation-negative glioblastoma. Journal of Neuro-Oncology. 133: 107-118 |
| Puduvalli V, Giglio P, Lehman N, et al. (2015) Rare-18Exceptional Responders: A Personalized Approach To Targeted Treatment Of Uncommon Brain Tumors. Neuro-Oncology. 17 |
| Van Brocklyn JR, Wojton J, Meisen WH, et al. (2014) Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Research. 74: 5364-70 |
| Bourekas EC, Bell SD, Ladwig NR, et al. (2014) Anaplastic papillary glioneuronal tumor with extraneural metastases. Journal of Neuropathology and Experimental Neurology. 73: 474-6 |
| Hong X, O'Donnell JP, Salazar CR, et al. (2014) The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stem-like cells and potentiates the effects of temozolomide and ionizing radiation. Cancer Chemotherapy and Pharmacology. 73: 983-90 |
| Mueller C, deCarvalho AC, Mikkelsen T, et al. (2014) Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations. Cancer Research. 74: 818-28 |